rs198550

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018896.5(CACNA1G):​c.1141-29A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.558 in 1,575,772 control chromosomes in the GnomAD database, including 250,866 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 26971 hom., cov: 32)
Exomes 𝑓: 0.55 ( 223895 hom. )

Consequence

CACNA1G
NM_018896.5 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.81

Publications

13 publications found
Variant links:
Genes affected
CACNA1G (HGNC:1394): (calcium voltage-gated channel subunit alpha1 G) Voltage-sensitive calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division, and cell death. This gene encodes a T-type, low-voltage activated calcium channel. The T-type channels generate currents that are both transient, owing to fast inactivation, and tiny, owing to small conductance. T-type channels are thought to be involved in pacemaker activity, low-threshold calcium spikes, neuronal oscillations and resonance, and rebound burst firing. Many alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Sep 2011]
CACNA1G Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • spinocerebellar ataxia type 42
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet, Illumina, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_018896.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 17-50575514-A-G is Benign according to our data. Variant chr17-50575514-A-G is described in ClinVar as Benign. ClinVar VariationId is 1192603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018896.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1G
NM_018896.5
MANE Select
c.1141-29A>G
intron
N/ANP_061496.2
CACNA1G
NM_198377.3
c.1141-29A>G
intron
N/ANP_938191.2O43497-20
CACNA1G
NM_198396.3
c.1141-29A>G
intron
N/ANP_938406.1O43497-33

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1G
ENST00000359106.10
TSL:1 MANE Select
c.1141-29A>G
intron
N/AENSP00000352011.5O43497-1
CACNA1G
ENST00000507336.5
TSL:1
c.1141-29A>G
intron
N/AENSP00000420918.1O43497-20
CACNA1G
ENST00000507510.6
TSL:1
c.1141-29A>G
intron
N/AENSP00000423112.2O43497-12

Frequencies

GnomAD3 genomes
AF:
0.588
AC:
89291
AN:
151950
Hom.:
26924
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.638
Gnomad AMI
AF:
0.326
Gnomad AMR
AF:
0.578
Gnomad ASJ
AF:
0.496
Gnomad EAS
AF:
0.935
Gnomad SAS
AF:
0.697
Gnomad FIN
AF:
0.572
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.536
Gnomad OTH
AF:
0.569
GnomAD2 exomes
AF:
0.600
AC:
133853
AN:
222978
AF XY:
0.598
show subpopulations
Gnomad AFR exome
AF:
0.645
Gnomad AMR exome
AF:
0.620
Gnomad ASJ exome
AF:
0.490
Gnomad EAS exome
AF:
0.938
Gnomad FIN exome
AF:
0.569
Gnomad NFE exome
AF:
0.530
Gnomad OTH exome
AF:
0.559
GnomAD4 exome
AF:
0.554
AC:
789265
AN:
1423704
Hom.:
223895
Cov.:
35
AF XY:
0.557
AC XY:
391411
AN XY:
702558
show subpopulations
African (AFR)
AF:
0.640
AC:
20849
AN:
32568
American (AMR)
AF:
0.618
AC:
25749
AN:
41642
Ashkenazi Jewish (ASJ)
AF:
0.490
AC:
12114
AN:
24706
East Asian (EAS)
AF:
0.948
AC:
36960
AN:
38984
South Asian (SAS)
AF:
0.673
AC:
55269
AN:
82066
European-Finnish (FIN)
AF:
0.564
AC:
29402
AN:
52112
Middle Eastern (MID)
AF:
0.511
AC:
2138
AN:
4186
European-Non Finnish (NFE)
AF:
0.527
AC:
573869
AN:
1088958
Other (OTH)
AF:
0.563
AC:
32915
AN:
58482
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
19179
38358
57538
76717
95896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16850
33700
50550
67400
84250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.588
AC:
89388
AN:
152068
Hom.:
26971
Cov.:
32
AF XY:
0.593
AC XY:
44100
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.639
AC:
26497
AN:
41466
American (AMR)
AF:
0.579
AC:
8845
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.496
AC:
1720
AN:
3470
East Asian (EAS)
AF:
0.935
AC:
4839
AN:
5178
South Asian (SAS)
AF:
0.694
AC:
3354
AN:
4830
European-Finnish (FIN)
AF:
0.572
AC:
6044
AN:
10570
Middle Eastern (MID)
AF:
0.469
AC:
138
AN:
294
European-Non Finnish (NFE)
AF:
0.536
AC:
36444
AN:
67958
Other (OTH)
AF:
0.574
AC:
1210
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1866
3733
5599
7466
9332
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
748
1496
2244
2992
3740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.553
Hom.:
98534
Bravo
AF:
0.589
Asia WGS
AF:
0.809
AC:
2809
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits (1)
-
-
1
Spinocerebellar ataxia type 42 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.053
DANN
Benign
0.35
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs198550;
hg19: chr17-48652875;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.